Global Bioinformatics Platforms 麻豆原创 Research Report 2023

Publication ID:

PB509239448

Publication Date:

September 29, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Bioinformatics platform combines statistical analysis modules to enable faster and easier analysis and integration and visualization of different types of big data generated through analysis of microbial genomes. Various bioinformatics tools for comparative analyses on gene level have been developed such as IMG/M, MicrobesOnline, MBGD, Roary, and EDGAR.
The global Bioinformatics Platforms market is projected to reach US$ 942.5 million in 2029, increasing from US$ 632 million in 2022, with the CAGR of 6.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Bioinformatics Platforms market research.
Key companies engaged in the Bioinformatics Platforms industry include Affymetrix, Dassault Systemes, Agilent Technologies, QIAGEN, ID Business Solutions, GenoLogics Life Sciences and Illumina, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Bioinformatics Platforms were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Bioinformatics Platforms market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Bioinformatics Platforms market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
Affymetrix
Dassault Systemes
Agilent Technologies
QIAGEN
ID Business Solutions
GenoLogics Life Sciences
Illumina
Segment by Type
Sequence Analysis Platforms
Sequence Alignment Platforms
Sequence Manipulation Platforms
Structural & Functional Analysis Platforms
Others
Segment by Application
Drug Development
Molecular Genomics
Personalized Medicine
Gene Therapy
Protein Function Analysis
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Bioinformatics Platforms report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. 麻豆原创 Opportunities and Challenges
Chapter 3: Companies鈥� Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies鈥� Outline
Chapter 12: 麻豆原创 Conclusions
Chapter 13: Research Methodology and Data Source

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Bioinformatics Platforms 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Sequence Analysis Platforms
1.2.3 Sequence Alignment Platforms
1.2.4 Sequence Manipulation Platforms
1.2.5 Structural & Functional Analysis Platforms
1.2.6 Others
1.3 麻豆原创 by Application
1.3.1 Global Bioinformatics Platforms 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Drug Development
1.3.3 Molecular Genomics
1.3.4 Personalized Medicine
1.3.5 Gene Therapy
1.3.6 Protein Function Analysis
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bioinformatics Platforms 麻豆原创 Perspective (2018-2029)
2.2 Bioinformatics Platforms Growth Trends by Region
2.2.1 Global Bioinformatics Platforms 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Bioinformatics Platforms Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Bioinformatics Platforms Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Bioinformatics Platforms 麻豆原创 Dynamics
2.3.1 Bioinformatics Platforms Industry Trends
2.3.2 Bioinformatics Platforms 麻豆原创 Drivers
2.3.3 Bioinformatics Platforms 麻豆原创 Challenges
2.3.4 Bioinformatics Platforms 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bioinformatics Platforms Players by Revenue
3.1.1 Global Top Bioinformatics Platforms Players by Revenue (2018-2023)
3.1.2 Global Bioinformatics Platforms Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Bioinformatics Platforms 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Bioinformatics Platforms Revenue
3.4 Global Bioinformatics Platforms 麻豆原创 Concentration Ratio
3.4.1 Global Bioinformatics Platforms 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bioinformatics Platforms Revenue in 2022
3.5 Bioinformatics Platforms Key Players Head office and Area Served
3.6 Key Players Bioinformatics Platforms Product Solution and Service
3.7 Date of Enter into Bioinformatics Platforms 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Bioinformatics Platforms Breakdown Data by Type
4.1 Global Bioinformatics Platforms Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Bioinformatics Platforms Forecasted 麻豆原创 Size by Type (2024-2029)
5 Bioinformatics Platforms Breakdown Data by Application
5.1 Global Bioinformatics Platforms Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Bioinformatics Platforms Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Bioinformatics Platforms 麻豆原创 Size (2018-2029)
6.2 North America Bioinformatics Platforms 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Bioinformatics Platforms 麻豆原创 Size by Country (2018-2023)
6.4 North America Bioinformatics Platforms 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bioinformatics Platforms 麻豆原创 Size (2018-2029)
7.2 Europe Bioinformatics Platforms 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Bioinformatics Platforms 麻豆原创 Size by Country (2018-2023)
7.4 Europe Bioinformatics Platforms 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bioinformatics Platforms 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Bioinformatics Platforms 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Bioinformatics Platforms 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Bioinformatics Platforms 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bioinformatics Platforms 麻豆原创 Size (2018-2029)
9.2 Latin America Bioinformatics Platforms 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Bioinformatics Platforms 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Bioinformatics Platforms 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bioinformatics Platforms 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Bioinformatics Platforms 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Bioinformatics Platforms 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Bioinformatics Platforms 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Affymetrix
11.1.1 Affymetrix Company Detail
11.1.2 Affymetrix Business Overview
11.1.3 Affymetrix Bioinformatics Platforms Introduction
11.1.4 Affymetrix Revenue in Bioinformatics Platforms Business (2018-2023)
11.1.5 Affymetrix Recent Development
11.2 Dassault Systemes
11.2.1 Dassault Systemes Company Detail
11.2.2 Dassault Systemes Business Overview
11.2.3 Dassault Systemes Bioinformatics Platforms Introduction
11.2.4 Dassault Systemes Revenue in Bioinformatics Platforms Business (2018-2023)
11.2.5 Dassault Systemes Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Detail
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Bioinformatics Platforms Introduction
11.3.4 Agilent Technologies Revenue in Bioinformatics Platforms Business (2018-2023)
11.3.5 Agilent Technologies Recent Development
11.4 QIAGEN
11.4.1 QIAGEN Company Detail
11.4.2 QIAGEN Business Overview
11.4.3 QIAGEN Bioinformatics Platforms Introduction
11.4.4 QIAGEN Revenue in Bioinformatics Platforms Business (2018-2023)
11.4.5 QIAGEN Recent Development
11.5 ID Business Solutions
11.5.1 ID Business Solutions Company Detail
11.5.2 ID Business Solutions Business Overview
11.5.3 ID Business Solutions Bioinformatics Platforms Introduction
11.5.4 ID Business Solutions Revenue in Bioinformatics Platforms Business (2018-2023)
11.5.5 ID Business Solutions Recent Development
11.6 GenoLogics Life Sciences
11.6.1 GenoLogics Life Sciences Company Detail
11.6.2 GenoLogics Life Sciences Business Overview
11.6.3 GenoLogics Life Sciences Bioinformatics Platforms Introduction
11.6.4 GenoLogics Life Sciences Revenue in Bioinformatics Platforms Business (2018-2023)
11.6.5 GenoLogics Life Sciences Recent Development
11.7 Illumina
11.7.1 Illumina Company Detail
11.7.2 Illumina Business Overview
11.7.3 Illumina Bioinformatics Platforms Introduction
11.7.4 Illumina Revenue in Bioinformatics Platforms Business (2018-2023)
11.7.5 Illumina Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Affymetrix
Dassault Systemes
Agilent Technologies
QIAGEN
ID Business Solutions
GenoLogics Life Sciences
Illumina

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.